期刊文献+

二甲双胍在多囊卵巢综合征应用中的研究进展 被引量:14

下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是一种内分泌紊乱性疾病,在育龄妇女中常见,是无排卵性不孕症中的常见原因,临床以高雄激素血症,排卵障碍或无排卵,卵巢多囊样改变为特征,常伴有胰岛素抵抗和肥胖.二甲双胍为胰岛素增敏剂,主要用于2型糖尿病患者的治疗.近20年来,二甲双胍在多囊卵巢综合征患者中的应用效果得到了越来越多的学者的关注.二甲双胍应用于多囊卵巢综合征效果显著,具有重要的临床意义.现对国内外研究成果做以综述,为临床治疗提供依据.
出处 《中国生育健康杂志》 2016年第3期298-300,共3页 Chinese Journal of Reproductive Health
  • 相关文献

参考文献28

  • 1Kubota T. Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan. Reprod Med Biol, 2013, 12: 71-77.
  • 2Palomba S, Falbo A, Russo T, et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcome . Fertil Steril, 2010,94 : 1805-1811.
  • 3Panidis D, Tziomalos K, Papadakis E, et al. Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery. Front Horm Res,2013,40 : 128-141.
  • 4Sirmans SM, Pate KA. Epidemiology diagnosis, and management of polyeystie ovary syndrome. Clin Epidemio1,2013,6 : 1-13.
  • 5Yavuz Taslipinar M, Kilie N, Bayraktar, et al. Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome. Turk J Med Sci ,2014,44:787-791.
  • 6Makled AK, EI Sherbiny M, Elkabarity R. Assessment of ovarian stromal blood flow after mefformin treatment in women with polyeystic ovary syndrome. Arch Gynecol Obstet, 2014, 289: 883-891.
  • 7Sivalingam VN, Myers J, Nicholas S, et al. Metformin in reproductive health, pregnancy and gynaeeological cancer: established and emerging indications. Hum Reprod Update ,2014,20:853-868.
  • 8Hwang KR, Choi YM, Kim JJ, et al. Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome. Clin Exp Reprod Med,2013 40 : 100-105.
  • 9唐婷婷.二甲双胍与达英-35治疗多囊卵巢综合征的临床疗效对比分析[J].中国实用医药,2014,9(34):9-10. 被引量:5
  • 10Chung JP, Yiu AK, Chung TK, et al. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol, 2014,27 : 166-171.

二级参考文献32

  • 1梁竹巍,王蕊.二甲双胍治疗多囊卵巢综合征新进展[J].国外医学(妇产科学分册),2006,33(6):414-417. 被引量:19
  • 2Diamanfi-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile[J]. J Clin Endocrinol Metab, 1999, 84:4006-4011.
  • 3Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77:1095-1105.
  • 4Glueck C J, Papanna R, Wang P, et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome[J]. Metabolism, 2003, 52(7): 908-915.
  • 5Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study[J]. J Clin Endocrinol Metab, 2005, 90(6): 3236-3242.
  • 6Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome[J]. J Hum Reprod Sci, 2009, 2( 1): 12-17.
  • 7Rizzo M, Berneis K, Hersberger M, et al. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype[J]. Hum Reprod, 2009, 24(9): 2286-2292.
  • 8Moran L J, Pasquali R, Teede HI, et al. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society[J]. Fertil Steril, 2009, 92(6): 1966-1982.
  • 9Diamanti-Kandarakis E, Economou F, Palimeri S, et al. Metformin in polycystic ovary syndrome[J]. Ann N Y Acad Sci, 2010, 1205: 192-198.
  • 10Dunaif A. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome-a reappraisal[J]. Nat Clin Pract Endocrinol Metab, 2008, 4(5): 272-283.

共引文献8

同被引文献82

引证文献14

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部